447 related articles for article (PubMed ID: 35972340)
21. The role of [
Civan C; Kuyumcu S; Has Simsek D; Sanli O; Isik EG; Ozkan ZG; Hurdogan O; Sanli Y
Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):852-861. PubMed ID: 37803246
[TBL] [Abstract][Full Text] [Related]
22. Head-to-head comparison of [
Ballal S; Yadav MP; Roesch F; Satapathy S; Moon ES; Martin M; Wakade N; Sheokand P; Tripathi M; Chandekar KR; Agarwal S; Sahoo RK; Rastogi S; Bal C
Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):233-244. PubMed ID: 37642703
[TBL] [Abstract][Full Text] [Related]
23. FAPI Compared with FDG PET/CT for Diagnosis of Primary and Metastatic Lung Cancer.
Wei Y; Ma L; Li P; Lu J; Ren J; Yan S; Wu H; Yuan S; Fu Z; Yu J
Radiology; 2023 Aug; 308(2):e222785. PubMed ID: 37552075
[TBL] [Abstract][Full Text] [Related]
24. Comparison of
Güzel Y; Kaplan İ
Hell J Nucl Med; 2023; 26(1):26-34. PubMed ID: 37031420
[TBL] [Abstract][Full Text] [Related]
25.
Kömek H; Can C; Güzel Y; Oruç Z; Gündoğan C; Yildirim ÖA; Kaplan İ; Erdur E; Yıldırım MS; Çakabay B
Ann Nucl Med; 2021 Jun; 35(6):744-752. PubMed ID: 33934311
[TBL] [Abstract][Full Text] [Related]
26. Comparisons of Quantitative Parameters of Ga-68-Labelled Fibroblast Activating Protein Inhibitor (FAPI) PET/CT and [
Siripongsatian D; Promteangtrong C; Kunawudhi A; Kiatkittikul P; Boonkawin N; Chinnanthachai C; Jantarato A; Chotipanich C
Mol Imaging Biol; 2022 Oct; 24(5):818-829. PubMed ID: 35486293
[TBL] [Abstract][Full Text] [Related]
27. Clinical utility of [
Zhao L; Pang Y; Zheng H; Han C; Gu J; Sun L; Wu H; Wu S; Lin Q; Chen H
Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3606-3617. PubMed ID: 33792760
[TBL] [Abstract][Full Text] [Related]
28. [
Yang L; Xu S; Cheng L; Gao C; Cao S; Chang Z; Wang K
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4051-4063. PubMed ID: 37542659
[TBL] [Abstract][Full Text] [Related]
29. [
Chen J; Xu K; Li C; Tian Y; Li L; Wen B; He C; Cai H; He Y
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4064-4076. PubMed ID: 37526694
[TBL] [Abstract][Full Text] [Related]
30. The potential utility of [
Lan L; Liu H; Wang Y; Deng J; Peng D; Feng Y; Wang L; Chen Y; Qiu L
Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):963-979. PubMed ID: 34410435
[TBL] [Abstract][Full Text] [Related]
31. Comparison of [
Chen H; Pang Y; Wu J; Zhao L; Hao B; Wu J; Wei J; Wu S; Zhao L; Luo Z; Lin X; Xie C; Sun L; Lin Q; Wu H
Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1820-1832. PubMed ID: 32222810
[TBL] [Abstract][Full Text] [Related]
32. Fibroblast Activation Protein-Targeted PET/CT with
Xu W; Cai J; Peng T; Meng T; Pang Y; Sun L; Wu H; Zhang J; Chen X; Chen H
J Nucl Med; 2024 Jan; 65(1):40-51. PubMed ID: 37884330
[TBL] [Abstract][Full Text] [Related]
33. First Clinical Experience With [68Ga]Ga-FAPI-46-PET/CT Versus [18F]F-FDG PET/CT for Nodal Staging in Cervical Cancer.
Wegen S; Roth KS; Weindler J; Claus K; Linde P; Trommer M; Akuamoa-Boateng D; van Heek L; Baues C; Schömig-Markiefka B; Schomäcker K; Fischer T; Drzezga A; Kobe C; Köhler C; Marnitz S
Clin Nucl Med; 2023 Feb; 48(2):150-155. PubMed ID: 36607364
[TBL] [Abstract][Full Text] [Related]
34. Dual-tracer PET/CT protocol with [
Wegen S; Weindler J; Voltin CA; van Heek L; Schomäcker K; Fischer T; Marnitz S; Kobe C; Drzezga A; Roth KS
Strahlenther Onkol; 2024 Jan; 200(1):28-38. PubMed ID: 37584717
[TBL] [Abstract][Full Text] [Related]
35. Comparison of [
Jiang D; Chen X; You Z; Wang H; Zhang X; Li X; Ren S; Huang Q; Hua F; Guan Y; Zhao J; Xie F
Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):732-742. PubMed ID: 34297193
[TBL] [Abstract][Full Text] [Related]
36. Utility of [
Miao Y; Feng R; Guo R; Huang X; Hai W; Li J; Yu T; Qu Q; Zhang M; Shangguan C; Mi J; Zhu Z; Li B
Eur Radiol; 2023 Jun; 33(6):4355-4366. PubMed ID: 36522509
[TBL] [Abstract][Full Text] [Related]
37.
Li C; Chen Q; Tian Y; Chen J; Xu K; Xiao Z; Zhong J; Wu J; Wen B; He Y
J Nucl Med; 2024 Apr; 65(4):527-532. PubMed ID: 38453362
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the diagnostic value of [
Lyu Y; Chen X; Liu H; Xi Y; Feng W; Li B
Eur J Nucl Med Mol Imaging; 2024 Mar; 51(4):1163-1172. PubMed ID: 38032383
[TBL] [Abstract][Full Text] [Related]
39. Oncologic Staging with
Demmert TT; Pomykala KL; Lanzafame H; Pabst KM; Lueckerath K; Siveke J; Umutlu L; Hautzel H; Hamacher R; Herrmann K; Fendler WP
J Nucl Med; 2023 Dec; 64(12):1906-1909. PubMed ID: 37734836
[TBL] [Abstract][Full Text] [Related]
40. Head-to-Head Comparison of 18 F-FDG and 68 Ga-FAPI-04 PET/CT for Radiological Evaluation of Cervical Cancer.
Shu Q; He X; Chen X; Liu M; Chen Y; Cai L
Clin Nucl Med; 2023 Nov; 48(11):928-932. PubMed ID: 37756446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
